CVS Health Corporation (NYSE:CVS)‘s stock had its “buy” rating reissued by equities research analysts at Credit Suisse Group AG in a note issued to investors on Tuesday. They currently have a $115.00 target price on the pharmacy operator’s stock. Credit Suisse Group AG’s price objective indicates a potential upside of 27.41% from the company’s previous close.

Several other research analysts have also recently commented on CVS. FBR & Co restated an “outperform” rating and set a $120.00 target price on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Leerink Swann restated a “buy” rating on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Zacks Investment Research upgraded shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, August 3rd. Morgan Stanley restated a “hold” rating and set a $104.00 target price on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Finally, Argus restated a “buy” rating and set a $120.00 target price on shares of CVS Health Corporation in a report on Thursday, August 4th. Six analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. CVS Health Corporation has an average rating of “Buy” and an average target price of $113.02.

Analyst Recommendations for CVS Health Corporation (NYSE:CVS)

CVS Health Corporation (NYSE:CVS) opened at 90.26 on Tuesday. The company has a market cap of $96.24 billion, a P/E ratio of 20.76 and a beta of 0.84. CVS Health Corporation has a 12-month low of $86.50 and a 12-month high of $106.67. The stock’s 50 day moving average is $94.41 and its 200 day moving average is $97.92.

CVS Health Corporation (NYSE:CVS) last announced its earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.02. CVS Health Corporation had a net margin of 2.88% and a return on equity of 15.86%. The business earned $43.70 billion during the quarter, compared to analysts’ expectations of $44.28 billion. During the same quarter in the prior year, the company posted $1.19 earnings per share. The firm’s revenue was up 17.6% on a year-over-year basis. On average, equities analysts forecast that CVS Health Corporation will post $5.86 earnings per share for the current year.

Several large investors have recently bought and sold shares of the stock. Trust Co. of Virginia VA increased its stake in CVS Health Corporation by 11.6% in the first quarter. Trust Co. of Virginia VA now owns 78,248 shares of the pharmacy operator’s stock worth $8,116,000 after buying an additional 8,136 shares during the last quarter. Fulton Bank N.A. increased its stake in CVS Health Corporation by 57.4% in the first quarter. Fulton Bank N.A. now owns 26,362 shares of the pharmacy operator’s stock worth $2,735,000 after buying an additional 9,615 shares during the last quarter. Chevy Chase Trust Holdings Inc. increased its stake in CVS Health Corporation by 1.9% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 1,415,310 shares of the pharmacy operator’s stock worth $146,809,000 after buying an additional 26,048 shares during the last quarter. Community Trust & Investment Co. increased its stake in CVS Health Corporation by 3.3% in the first quarter. Community Trust & Investment Co. now owns 182,198 shares of the pharmacy operator’s stock worth $18,900,000 after buying an additional 5,802 shares during the last quarter. Finally, Iowa State Bank increased its stake in CVS Health Corporation by 1.0% in the first quarter. Iowa State Bank now owns 18,768 shares of the pharmacy operator’s stock worth $1,947,000 after buying an additional 190 shares during the last quarter. Institutional investors own 80.96% of the company’s stock.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

5 Day Chart for NYSE:CVS

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.